Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation

Tools

Item Type:	Letter
Title:	Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
Creators:	Siegert, E., Biesen, R. ORCID: https://orcid.org/0000-0002-0434-7832, Dzamukova, M. ORCID: https://orcid.org/0000-0002-2389-3222, Furth, C., Probst, M. ORCID: https://orcid.org/0009-0004-3390-6789, Doellinger, F. ORCID: https://orcid.org/0000-0003-3661-8569, Walter-Rittel, T., Fleischmann, A., Wilhelm, A., Beenken, A.E., Wiebe, E., Pecher, A.C. ORCID: https://orcid.org/0000-0003-0201-0686, Henes, J. ORCID: https://orcid.org/0000-0002-8385-6861, Florian, S., Simon, D., Kleyer, A., Burmester, G.R., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Krönke, J., Krönke, G. and Alexander, T. ORCID: https://orcid.org/0000-0003-1193-0097
Source:	Annals of the Rheumatic Diseases
ISSN:	0003-4967
Publisher:	Elsevier / European Alliance of Associations for Rheumatology (EULAR)
Volume:	84
Number:	4
Page Range:	653-656
Date:	April 2025
Official Publication:	https://doi.org/10.1016/j.ard.2025.01.043
PubMed:	View item in PubMed

Repository Staff Only: item control page